Skip to main content

Table 1 Salirasib induced decrease in cell number after 7 days of treatment

From: Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition

  

Salirasib treatment

  

50 μM

100 μM

150 μM

 

HepG2 (S.E.M.)

54%*** (±5%)

34% *** (±3%)

2% *** (±0%)

Cell line

Huh7 (S.E.M.)

70%** (±6%)

52%*** (±3%)

1%*** (±0%)

 

Hep3B (S.E.M.)

31%*** (±3%)

5%*** (±0%)

0%***

  1. Data (means ± S.E.M.) are expressed as relative change compared with the control group (DMSO) ** P < 0.01 and *** P < 0.001